Osteoporosis and multiple fractures in an antiretroviral-naive, HIV-positive child

Journal of Pediatric Endocrinology and Metabolism

Volumn 20, Issue 8, 2007, Pages 933-938

  Soler Palacin, P ^a   Torrent, A ^a   Rossich, R ^a   Moraga, F A ^a   Yeste, D ^a   Carreno J C ^a   Encabo, G ^a   Figueras, C ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Alendronate; Bisphosphonates; HAART; Osteoporosis HIV

Indexed keywords

ALENDRONIC ACID; ANTIFUNGAL AGENT; ANTIRETROVIRUS AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; COLECALCIFEROL; COTRIMOXAZOLE; LAMIVUDINE; METRONIDAZOLE; MYCONAZOLE; NELFINAVIR; OPIATE; UNCLASSIFIED DRUG; ZIDOVUDINE;

ARTICLE; BONE DENSITOMETRY; BONE MASS; CASE REPORT; CHILD CARE; CLINICAL FEATURE; DISEASE SEVERITY; DRUG RESPONSE; FEMALE; GIARDIASIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIMB FRACTURE; NUTRITIONAL SUPPORT; OSTEOPOROSIS; PATHOLOGIC FRACTURE; PELVIS PAIN SYNDROME; PHYSIOTHERAPY; PNEUMOCYSTOSIS; PRESCHOOL CHILD; RIB FRACTURE; THRUSH; TREATMENT DURATION; VERTEBRA FRACTURE; VERTICAL TRANSMISSION; VITAMIN SUPPLEMENTATION;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHILD; DIPHOSPHONATES; FEMALE; FRACTURES, BONE; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; OSTEOPOROSIS; TREATMENT OUTCOME;

EID: 34648843105     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Mondy K, Tebas P. Emerging bone problems in patients infected with human immunodeficiency virus. Clin Infect Dis 2003; 36: S101-S105.
2. Rojo Conejo P, Ramos Amador JT, García Piñar L, Ruano Fajardo C, Sánchez Granados JM, González Tomé MI, Ruiz Contreras J. Decreased bone mineral density in HIV-infected children receiving highly active antiretroviral therapy. An Pediatr (Barc) 2004; 60: 249-253.
3. Annapoorna N, Venkateswara Rao G, Reddy NS, Rambabu P, Samabasiva Rao KRS. An increased risk of osteoporosis during acquired immunodeficiency syndrome. Int J Med Sci 2004; 1: 152-164.
4. Morn S, Zamproni I, Beccio S, Bianchi R, Giacomet V, Vigano A. Longitudinal changes of bone mineral density and metabolism in antiretroviral-treated human immunodeficiency virus-infected children. J Clin Endocrinol Metab 2004; 89: 24-28.
5. Amorosa V, Tebas P. Bone disease and HIV infection. Clin Infect Dis 2006; 42: 108-114.
6. Tebas P, Powderly WG, Claxton S, Marin D, Tantisiriwat W, Teitelbaum SL, Yarasheski KE. Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy. AIDS 2000; 14: F63-67.
7. Moore AL, Vashisht A, Sabin CA, Mocroft A, Madge S, Phillips AN, Studd JW, Johnson MA. Reduced bone mineral density in HIV-positive individuals. AIDS 2001; 15: 1731-1733.
8. Garcia Aparicio AM, Muñoz Fernández S, González J, Arribas JR, Pena JM, Vázquez JJ, Martínez ME, Coya J, Martin Mola E. Abnormalities in the bone mineral metabolism in HIV-infected patients. Clin Rheumatol 2005; 6: 1-3.
9. Bruera D, Luna N, David DO, Bergoglio LM, Zamudio J. Decreased bone mineral density in HIV-infected patients is independent of antiretroviral therapy. AIDS. 2003; 17: 1917-1923.
10. Mondy K, Powderly WG, Claxton SA, Yarasheski K, Royal M, Stoneman J, Hoffmann ME, Tebas P. Alendronate, vitamin D and calcium for the treatment of osteopenia/osteoporosis associated with HIV infection. J Acquir Immune Defic Syndr 2005; 38: 426-431.
11. Guaraldi G, Orlando G, Madeddu G, Vescini F, Ventura P, Campostrini S, Mura MS, Parise N, Caudarella R, Esposito R. Alendronate reduces bone resorption in HIV-associated osteopenia/osteoporosis. HIV Clin Trials 2004; 5: 269-277.
12. Negredo E, Martinez-Lopez E, Paredes R, Rosales J, Perez Alvarez N, Holgado S. Reversal of HIV-1-associated osteoporosis with once-weekly alendronate. AIDS 2005; 19: 343-345.
13. Polo R, José Galindo M, Martínez E, Alvarez J, Arévalo JM, Asensi V, Cánoves D, Cáncer E, Collazos J, Estrada V, Gómez-Candela C, Johnston S, Locutura J, López-Aldeguer J, Lozano F, Miralles C, Muñoz-Sanz A, Ortega E, Pascua J, Pedrol E, Pulido F, San Martín M, Sanz J, Viciana P, Chamorro L; Study Group for Metabolic Alterations/Secretariat for the National AIDS Plan (GEAM/SPNS). Recomendaciones de GEAM/SPNS sobre el tratamiento de las alteraciones metabólicas y morfológicas en el paciente con infección por VIH. Enferm Infecc Microbiol Clin 2006; 24: 96-117.
14. Caldwell MB, Oxtoby MS, Simonds RJ, Rogers MF. 1994 revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR 1994; 43: 1-10.
15. Del Rio L, Carrascosa A, Pons F, Gusinye M, Yeste D, Domenech FM. Bone mineral density of the lumbar spine in White Mediterranean Spanish children and adolescents: changes related to age, sex, and puberty. Pediatr Res 1994; 35: 362-366.
16. Landonio S, Quirino T, Bonfanti P, Gabris A, Boccassini L, Gulisano C, Vulpio L, Ricci E, Carrabba M, Vigevani GM. Osteopenia and osteoporosis in HIV+patients, untreated or receiving HAART. Biomed Pharmacother 2004; 58: 505-508.
17. Baroncelli GI, Bertelloni S, Sodini F, Saggese G. Osteoporosis in children and adolescents. Pediatr Drugs 2005; 7: 295-315.
18. Serrano S, Marinoso M, Soriano J, Rubies-Prat J, Aubia J, Coll J, Bosch J, Del Rio L, Vila J, Goday A, et al. Bone remodelling in human immunodeficiency virus-1-infected patients: a histomorphometric study. Bone 1995; 16: 195-191.
19. McComsey GA, Huang JS, Woolley IJ, Young B, Sax PE, Gerber M, Swindells S, Bonilla H, Gopalakrishnan G. Fragility fractures in HIV-infected patients: need for better understanding of diagnosis and management. J Int Assoc Physicians AIDS Care (Chic III) 2004; 3: 86-91.
20. Arpadi S, Horlick M, Shane E. Metabolic bone disease in human immunodeficiency virus-infected children. J Clin Endocrinol Metab 2004; 9: 21-23.
21. Pitukcheewanont P, Safani D, Church J, Gilsanz V. Bone measures in HIV-1 infected children and adolescents: disparity, between quantitative computed tomography and dual-energy X-ray absorptiometry measurements. Osteoporos Int 2005; 16: 1393-1396.
22. Rosso R, Vignolo M, Parodi A, Di Biagio A, Sormani MP, Bassetti M, Aicardi G, Bassetti D. Bone quality in parinatally HIV-infected children: role of age, sex, growth, HIV infection, and antiretroviral therapy. AIDS Res Hum Retroviruses 2005; 2l: 927-932.
23. Unal E, Abaci A, Bober E, Buyukgebiz A. Efficacy and safety of oral alendronate treatment in children and adolescents with osteoporosis. J Pediatr Endocrinol Metab 2006; 19: 523-528.